Status:
COMPLETED
To Evaluate the Use of Radiomics to Classify Between Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease
Lead Sponsor:
Maastricht University
Collaborating Sponsors:
Université Libre de Bruxelles
Conditions:
Interstitial Lung Disease
Idiopathic Pulmonary Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
To investigate the ability of machine learning models based on radiomic features extracted from thin-section CT images to differentiate IPF patients from non-IPF interstitial lung diseases.
Eligibility Criteria
Inclusion
- UIP with final diagnosis in biopsy
- ILDs with final diagnosis in biopsy
Exclusion
- patients with no biopsy confirmation
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2017
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04430491
Start Date
January 1 2005
End Date
July 1 2017
Last Update
June 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University
Maastricht, Limburg, Netherlands, 6229ER